Moderna sizes up private COVID vaccine market in US, where shots could cost $100 a pop

Assuming half of the U.S. adult population of about 258 million people receives an annual booster, Moderna and Pfizer could be looking at a private vaccine market worth about $12.9 billion annually. That assumption hinges (PDF) on a potential shot price tag of $100.